Biofrontera Inc. Other Receivables, Net, Current
Biofrontera Inc. (BFRI) had Other Receivables, Net, Current of $1.00 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:OtherReceivablesNetCurrent · last filed 2026-08-13
- 2026-06-30: Other Receivables, Net, Current $1.00M.
- 2026-03-31: Other Receivables, Net, Current $1.30M.
- 2025-12-31: Other Receivables, Net, Current $4.80M.
- 2024-12-31: Other Receivables, Net, Current $5.30M.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2026-06-30 | $1.00M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.30M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $4.80M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $5.30M 10-K · filed 2026-03-19 |
| 2023-03-31 | $3.75M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $3.66M 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |